Ryon P Graf (Ryon Graf)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 27

Top Topics

Sensitive Detection

Tyrosine Kinase

Radical Prostatectomy

Circulating Tumor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Shilpa Gupta, Tu My To, Ryon P Graf, Edward E Kadel, Norelle Reilly, Husam Albarmawi
Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
Miles C Andrews, Gerald Li, Ryon P Graf, Virginia A Fisher, Jerry Mitchell, Ali Aboosaiedi, Harriet O'Rourke, Mark Shackleton, Mahesh Iddawela, Geoffrey R Oxnard, Richard S P Huang
Predictive Impact of Tumor Mutational Burden on Real-World Outcomes of First-Line Immune Checkpoint Inhibition in Metastatic Melanoma. JCO precision oncology 8 (2024)
Shilpa Gupta, Tu My To, Ryon P Graf, Edward E Kadel, Norelle Reilly, Husam Albarmawi
Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, Derek W Brown, Yanmei Huang, Jason D Hughes, Ryon P Graf, Geoffrey R Oxnard, Hatim Husain
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Debra L Richardson, Julia Coelho França Quintanilha, Natalie Danziger, Gerald Li, Ethan S Sokol, Alexa B Schrock, Ericka M Ebot, Neeru Bhardwaj, Tanesha Norris, Anosheh Afghahi, Anthony Frachioni, Christina R Washington, Lauren Dockery, Julia A Elvin, Ryon P Graf, Kathleen M Moore
Effectiveness of PARP inhibitor maintenance therapy in ovarian cancer by BRCA1/2 and a scar-based HRD signature in real-world practice. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, Derek W Brown, Yanmei Huang, Jason D Hughes, Ryon P Graf, Geoffrey R Oxnard, Hatim Husain
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Christopher J Sweeney, Russell Petry, Chang Xu, Merrida Childress, Jie He, David Fabrizio, Ole V Gjoerup, Samantha Morley, Timothy Catlett, Zoe June Assaf, Kobe Yuen, Matthew J Wongchenko, Kalpit Shah, Pratyush Gupta, Priti S Hegde, Lincoln W Pasquina, Sanjeev Mariathasan, Ryon P Graf, Thomas Powles
Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, Derek W Brown, Yanmei Huang, Jason D Hughes, Ryon P Graf, Geoffrey R Oxnard, Hatim Husain
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Christian D Rolfo, Russell W Madison, Lincoln W Pasquina, Derek W Brown, Yanmei Huang, Jason D Hughes, Ryon P Graf, Geoffrey R Oxnard, Hatim Husain
Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Shilpa Gupta, Tu My To, Ryon P Graf, Edward E Kadel, Norelle Reilly, Husam Albarmawi
Real-World Overall Survival and Treatment Patterns by PTEN Status in Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 8 (2024)
Julia Coelho França Quintanilha, Ryon P Graf, Geoffrey R Oxnard
BRAF V600E and RNF43 Co-mutations Predict Patient Outcomes With Targeted Therapies in Real-World Cases of Colorectal Cancer. The oncologist (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Pashtoon Murtaza Kasi, Jessica K Lee, Lincoln W Pasquina, Brennan Decker, Pierre Vanden Borre, Dean C Pavlick, Justin M Allen, Christine Parachoniak, Julia Coelho França Quintanilha, Ryon P Graf, Alexa B Schrock, Geoffrey R Oxnard, Christine M Lovly, Hanna Tukachinsky, Vivek Subbiah
Circulating tumor DNA enables sensitive detection of actionable gene fusions and rearrangements across cancer types. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Julia C F Quintanilha, Michael H Storandt, Ryon P Graf, Gerald Li, Rachel B Keller, Douglas I Lin, Jeffery S Ross, Richard S P Huang, Alexa B Schrock, Geoffrey R Oxnard, Sakti Cjakrabarti, Amit Mahipal
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness. JCO precision oncology 7 (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Richard S P Huang, David P Carbone, Gerald Li, Alexa Schrock, Ryon P Graf, Liangliang Zhang, Karthikeyan Murugesan, Jeffrey S Ross, Khaled Tolba, Jacob Sands, Geoffrey R Oxnard, David Spigel
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Journal for immunotherapy of cancer 11 (1) (2023)
Julia Coelho França Quintanilha, Ryon P Graf, Geoffrey R Oxnard
BRAF V600E and RNF43 Co-mutations Predict Patient Outcomes With Targeted Therapies in Real-World Cases of Colorectal Cancer. The oncologist 28 (3) (2023)
Amado J Zurita, Ryon P Graf, Guillermo Villacampa, Kira Raskina, Ethan S Sokol, Dexter Jin, Emmanuel S Antonarakis, Gerald Li, Richard S P Huang, Irene Casanova-Salas, Ana Vivancos, Joan Carles, Jeffery S Ross, Alexa B Schrock, Geoffrey R Oxnard, Joaquin Mateo
Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies. JCO precision oncology 6 (2022)
Ryon P Graf, Virginia Fisher, James Creeden, Alexa B Schrock, Jeffery S Ross, Halla Nimeiri, Geoffrey R Oxnard, Samuel J Klempner
Real-world Validation of TMB and Microsatellite Instability as Predictive Biomarkers of Immune Checkpoint Inhibitor Effectiveness in Advanced Gastroesophageal Cancer. Cancer research communications 2 (9) (2022)
Hope S Rugo, Kira Raskina, Alexa B Schrock, Russell W Madison, Ryon P Graf, Ethan S Sokol, Smruthy S Sivakumar, Jessica K Lee, Virginia A Fisher, Geoffrey R Oxnard, Hanna Tukachinsky
Biology and targetability of the extended spectrum of PIK3CA mutations (PIK3CAm) detected in breast carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Corbin J Eule, Thomas W Flaig, Katy Wong, Ryon P Graf, Elaine T Lam
Effectiveness and durability of benefit of mTOR inhibitors in a real-world cohort of patients with metastatic prostate cancer and PI3K pathway alterations. Prostate cancer and prostatic diseases (2022)
Jake G Maule, Lani K Clinton, Ryon P Graf, Jinpeng Xiao, Geoffrey R Oxnard, Jeffrey S Ross, Richard S P Huang
Comparison of PD-L1 tumor cell expression with 22C3, 28-8, and SP142 IHC assays across multiple tumor types. Journal for immunotherapy of cancer 10 (10) (2022)
Emmanuel S Antonarakis, Marni Tierno, Virginia A Fisher, Hanna Tukachinsky, Sonja Alexander, Omar Hamdani, Matthew C Hiemenz, Richard S P Huang, Geoffrey R Oxnard, Ryon P Graf
Clinical and pathological features associated with circulating tumor DNA content in real-world patients with metastatic prostate cancer. The Prostate 82 (7) (2022)
Ryon P Graf, Virginia Fisher, Richard S P Huang, Omar Hamdani, Ole V Gjoerup, Jennifer Stanke, James Creeden, Mia A Levy, Geoffrey R Oxnard, Shilpa Gupta
Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma. JCO precision oncology 6 (2022)
Umang Swami, Ryon P Graf, Roberto H Nussenzveig, Virginia A Fisher, Hanna Tukachinsky, Alexa B Schrock, Gerald Li, Jeffery S Ross, Nicolas Sayegh, Nishita Tripathi, Vinay M Thomas, Geoffrey R Oxnard, Emmanuel S Antonarakis, Archana M Agarwal
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (22) (2022)